Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04085315
Title Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Collin Blakely
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.